The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Borrower

H••••••••• I••

Drug Discovery & Developmentgroup grade Aon a schedule nowsponsor unattributed
Also written as: 2021; 5; 5/7/2021; 7; Equity
Principal held
unknown
sum of BDC pieces, a lower bound
Fair value
$239,000
n/a on cost, debt pieces
Unfunded
n/a
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
1
1 equity pieces beside them
Next maturity
unstated
no dated debt inside 24 months
On the tape since
Dec 31, 2022
latest Jun 30, 2026
Events
1
dated, non-routine
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
FacilityHeldOn costPricingMaturityBDCs
first lien term loan first lien
exited Mar 31, 2025
at least $1.6M100cS+540 bpMay 1, 20251
Equity pieces beside the debt: preferred equity ($239,000 fair value, 1 BDC)
Lenders
every BDC piece at the latest quarter end
BDCInstrumentPrincipalFair valueRate
H••••••• C••••••• I•••preferred equity equity
Preferred Series B
n/a$239,000
6c
Through time
the borrower's pieces summed across BDCs, every quarter end
Quarter endBDCsPrincipal heldFair valueOn costPIK pieces
Jun 30, 20261$0$0n/a0
Mar 31, 20261$0$0n/a0
Dec 31, 20251$0$0n/a0
Sep 30, 20251$0$0n/a0
Jun 30, 20251$0$0n/a0
Mar 31, 20251$1.6M$2.4M100c0
Dec 31, 20241$7.9M$9.5M100c0
Sep 30, 20241$6.2M$7.0M100c0
Jun 30, 20241$8.4M$9.0M99c0
Mar 31, 20241$10.5M$11.0M99c0
Dec 31, 20231$37.6M$39.5M100c0
Sep 30, 20231$14.5M$15.0M100c0
Jun 30, 20231$16.4M$16.8M100c0
Mar 31, 20231$17.0M$17.4M100c0
Dec 31, 20221$17.0M$17.3M100c0
What changed
Every change including routine ones
Identity
Group key
HIBERCELLderivedthe codename stem after legal suffixes and deal words
Spellings
1 across 1 BDCderived
Industry
Drug Discovery & Developmentreportedas one filer wrote it